TickerFacts.

A business in context

VTVT research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-20 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-10-01 · 0001641489-26-000032 · Items 5.03,9.01

  2. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001641489-26-000030

  3. 8-K · Current report

    Report date 2026-08-06 · 0001641489-26-000029 · Items 2.02,9.01

  4. 4 · Ownership change

    Report date 2026-06-26 · 0001928247-26-000003

  5. 8-K · Current report

    Report date 2026-06-26 · 0001641489-26-000024 · Items 5.07

  6. 4 · Ownership change

    Report date 2026-06-26 · 0001627680-26-000006

  7. 4 · Ownership change

    Report date 2026-06-26 · 0001253170-26-000008

  8. 4 · Ownership change

    Report date 2026-06-26 · 0001238403-26-000006

  9. 4 · Ownership change

    Report date 2026-06-26 · 0001193125-26-288602

  10. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001641489-26-000020

  11. 8-K · Current report

    Report date 2026-05-13 · 0001641489-26-000019 · Items 2.02,9.01

  12. 8-K · Current report

    Report date 2026-05-13 · 0001193125-26-221971 · Items 8.01,9.01

  13. DEF 14A · Proxy statement

    Report date 2026-06-10 · 0001641489-26-000015

  14. 8-K · Current report

    Report date 2026-03-10 · 0001641489-26-000012 · Items 7.01,9.01

  15. 8-K · Current report

    Report date 2026-03-10 · 0001641489-26-000011 · Items 2.02,9.01

  16. 10-K · Annual report

    Report date 2025-12-31 · 0001641489-26-000010

  17. 8-K · Current report

    Report date 2026-02-26 · 0001641489-26-000005 · Items 7.01,9.01

  18. 4 · Ownership change

    Report date 2026-02-17 · 0002069755-26-000003

  19. 4 · Ownership change

    Report date 2026-02-17 · 0001264519-26-000002

  20. 8-K · Current report

    Report date 2026-01-30 · 0001641489-26-000002 · Items 1.01

  21. 8-K · Current report

    Report date 2025-12-19 · 0001641489-25-000066 · Items 5.03,9.01

  22. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001641489-25-000060

  23. 8-K · Current report

    Report date 2025-11-06 · 0001641489-25-000058 · Items 2.02,9.01

  24. 4 · Ownership change

    Report date 2025-09-22 · 0001231919-25-000247

  25. 8-K · Current report

    Report date 2025-09-10 · 0001641489-25-000055 · Items 7.01

  26. 8-K · Current report

    Report date 2025-08-29 · 0001193125-25-193486 · Items 1.01,9.01

  27. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001641489-25-000053

  28. 8-K · Current report

    Report date 2025-08-12 · 0001641489-25-000051 · Items 2.02,9.01

  29. 8-K · Current report

    Report date 2025-06-10 · 0001641489-25-000038 · Items 5.07

  30. 8-K · Current report

    Report date 2025-05-19 · 0001641489-25-000032 · Items 5.02,9.01

  31. 8-K · Current report

    Report date 2025-05-16 · 0001641489-25-000030 · Items 7.01,9.01

  32. 8-K · Current report

    Report date 2025-05-15 · 0001641489-25-000028 · Items 2.02,9.01

  33. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001641489-25-000026

  34. DEF 14A · Proxy statement

    Report date 2025-06-10 · 0001641489-25-000024

  35. 8-K · Current report

    Report date 2025-04-11 · 0001641489-25-000018 · Items 5.02

  36. 8-K · Current report

    Report date 2025-03-31 · 0001641489-25-000016 · Items 7.01,9.01

  37. 10-K · Annual report

    Report date 2024-12-31 · 0001641489-25-000014

  38. 8-K · Current report

    Report date 2025-03-20 · 0001641489-25-000013 · Items 2.02,9.01

  39. 8-K · Current report

    Report date 2025-03-14 · 0001641489-25-000010 · Items 8.01,9.01

  40. 8-K · Current report

    Report date 2025-02-24 · 0001641489-25-000005 · Items 5.02

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001641489vTv Therapeutics Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$1.02M$1.09M
    2023-12-31$0$0
    2022-12-31$2.02M$2.32M
    2021-12-31$4.00M$4.98M
    2020-12-31$6.41M$8.35M
    2019-12-31$2.76M$3.64M
    2018-12-31$12.43M$16.68M
    2017-12-31$291.0K$400.0K

    Bureau of Labor Statistics · retrieved 2026-10-20 · 9 selected series; gaps remain missing

    Explore the CPI history ↗